N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549)

Free Radical Research

Volumn 47, Issue 9, 2013, Pages 740-749

  Tobwala, S ^a   Fan, W ^a   Stoeger, T ^b   Ercal, N ^a  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Bleomycin; GSH prodrug; N acetylcysteine amide; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BLEOMYCIN; GLUTATHIONE; MALONALDEHYDE; N ACETYLCYSTEINE AMIDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; UNCLASSIFIED DRUG; ACETYLCYSTEINE; N-ACETYLCYSTEINAMIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; MEDIATOR; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; SCAVENGING SYSTEM; ANALOGS AND DERIVATIVES; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; LUNG; METABOLISM;

STREPTOMYCES VERTICILLUS;

ACETYLCYSTEINE; ANTIOXIDANTS; BLEOMYCIN; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LUNG; OXIDATIVE STRESS; PNEUMOCYTES; REACTIVE OXYGEN SPECIES;

EID: 84882434200     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.819974     Document Type: Article

References (81)

1. Lazo JS, Chabner BA. Cancer chemotherapy and biotherapy: principles and practice. In: Chabner BA, Longo DL (eds.). Philadelphia: Lippincott-Raven, 1996. pp. 379-394.
2. Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000; 63: 158-168.
3. Chandler DB. Possible mechanisms of bleomycin-induced fi brosis. Clin Chest Med 1990; 11: 21-30.
4. Smith RE, Strieter RM, Phan SH, Kunkel SL. C-C chemokines: novel mediators of the profi brotic infl ammatory response to bleomycin challenge. Am J Respir Cell Mol Biol 1996; 15: 693-702.
5. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, Strieter RM. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fi brosis via inhibition of angiogenesis. J Immunol 1999; 163: 5686-5692.
6. Parizada B, Werber MM, Nimrod A. Protective eff ects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fi brosis. Free Radic Res Commun 1991; 15: 297-301.
7. Habib MP, Lackey DL, Lantz RC, Sobonya RE, Grad R, Earnest DL, Bloom JW. Vitamin A pretreatment and bleomycin induced rat lung injury. Res Commun Chem Pathol Pharmacol 1993; 81: 199-208.
8. Karam H, Hurbain-Kosmath I, Housset B. Antioxidant activity in alveolar epithelial type 2 cells of rats during the development of bleomycin injury. Cell Biol Toxicol 1998; 14: 13-22.
9. Patel RB, Kotha SR, Sauers LA, Malireddy S, Gurney TO, Gupta NN, et al. Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fi brosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-mercaptoethyl isophthalamide. Toxicol Mech Methods 2012; 22: 383-396.
10. Cross CE, Warren D, Gerriets JE, Wilson DW, Halliwell B, Last JA. Deferoxamine injection does not aff ect bleomycininduced lung fi brosis in rats. J Lab Clin Med 1985; 106: 433-438.
11. Dedon PC, Goldberg IH. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem Res Toxicol 1992; 5: 311-332.
12. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fi brosis. Am J Respir Crit Care Med 1997; 155: 1763-1769.
13. Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fi brosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989; 139: 373-377.
14. Lakari E, Soini Y, Saily M, Koistinen P, Paakko P, Kinnula VL. Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 2002; 117: 132-142.
15. Galvan L, Huang CH, Prestayko AW, Stout JT, Evans JE, Crooke ST. Inhibition of bleomycin-induced DNA breakage by superoxide dismutase. Cancer Res 1981; 41: 5103-5106.
16. Cunningham ML, Ringrose PS, Lokesh BR. Inhibition of the genotoxicity of bleomycin by superoxide dismutase. Mutat Res 1984; 135: 199-202.
17. Hagiwara SI, Ishii Y, Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fi brosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000; 162: 225-231.
18. Tamagawa K, Taooka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M. Inhibitory eff ects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fi brosis in mice. Am J Respir Crit Care Med 2000; 161: 1279-1284.
19. Rahman I, Skwarska E, Henry M, Davis M, O'Connor CM, FitzGerald MX, et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fi brosis. Free Radic Biol Med 1999; 27: 60-68.
20. Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, Mora AL, et al. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fi brosis. Am J Physiol Lung Cell Mol Physiol 2009; 296: L37-45.
21. Berend N. Inhibition of bleomycin lung toxicity by N-acetyl cysteine in the rat. Pathology 1985; 17: 108-110.
22. Jamieson DD, Kerr DR, Unsworth I. Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice. Lung 1987; 165: 239-247.
23. Ward HE, Nicholson A, Berend N. Failure of systemic N-acetyl cysteine to protect the rat lung against bleomycin toxicity. Pathology 1987; 19: 358-360.
24. Giri SN, Hyde DM, Schiedt MJ. Eff ects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of diff erent tissues and bleomycin-induced lung fi brosis in hamsters. J Lab Clin Med 1988; 111: 715-724.
25. Shahzeidi S, Sarnstrand B, Jeff ery PK, McAnulty RJ, Laurent GJ. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice. Eur Respir J 1991; 4: 845-852.
26. Cortijo J, Cerda-Nicolas M, Serrano A, Bioque G, Estrela JM, Santangelo F, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 2001; 17: 1228-1235.
27. Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. Antioxidative and clinical eff ects of high-dose N-acetylcysteine in fi brosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997; 156: 1897-1901.
28. Serrano-Mollar A, Closa D, Cortijo J, Morcillo EJ, Prats N, Gironella M, et al. P-selectin upregulation in bleomycin induced lung injury in rats: eff ect of N-acetyl-L-cysteine. Thorax 2002; 57: 629-634.
29. Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, et al. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 2003; 138: 1037-1048.
30. Behr J, Degenkolb B, Krombach F, Vogelmeier C. Intracellular glutathione and bronchoalveolar cells in fi brosing alveolitis: eff ects of N-acetylcysteine. Eur Respir J 2002; 19: 906-911.
31. Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fi brosis and normals. Am J Respir Crit Care Med 1995; 152: 1055-1060.
32. Meyer A, Buhl R, Magnussen H. The eff ect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fi brosis. Eur Respir J 1994; 7: 431-436.
33. Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997; 38: 205-227.
34. Banerjee A, Trueblood MB, Zhang X, Manda KR, Lobo P, Whitefi eld PD, et al. N-acetylcysteineamide (NACA) prevents infl ammation and oxidative stress in animals exposed to diesel engine exhaust. Toxicol Lett 2009; 187: 187-193.
35. Carey JW, Tobwala S, Zhang X, Banerjee A, Ercal N, Pinarci E, Karacal H. N-Acetyl L-cysteine amide protects retinal pigment epithelium against methamphetamine-induced oxidative stress. J Biophys Chem 2012; 3: 101-110.
36. Carey JW, Pinarci Y, Penugonda S, Karacal H, Ercal N. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide. Free Radical Bio Med 2011; 50: 722-729.
37. Grinberg L, Fibach E, Amer J, Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radical Bio Med 2005; 38: 136-145.
38. Penugonda S, Ercal N. Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice. Toxicol Lett 2011; 201: 1-7.
39. Schimel AM, Abraham L, Cox D, Sene A, Kraus C, Dace DS, et al. N-acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation. Am J Pathol 2011; 178: 2032-2043.
40. Zhang X, Banerjee A, Banks WA, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009; 1275: 87-95.
41. Zhang X, Tobwala S, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice. Hum Exp Toxicol 2012; 31: 931-944.
42. Off en D, Gilgun-Sherki Y, Barhum Y, Benhar M, Grinberg L, Reich R, et al. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 2004; 89: 1241-1251.
43. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofl uorescein assay using microplate reader. Free Radic Biol Med 1999; 27: 612-616.
44. Winters RA, Zukowski J, Ercal N, Matthews RH, Spitz DR. Analysis of glutathione, glutathione disulfi de, cysteine, homocysteine, and other biological thiols by high-performance liquid chromatography following derivatization by n-(1- pyrenyl)maleimide. Anal Biochem 1995; 227: 14-21.
45. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 1993; 15: 353-363.
46. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
47. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.
48. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
49. Weissler JC. Idiopathic pulmonary fi brosis: cellular and molecular pathogenesis. Am J Med Sci 1989; 297: 91-104.
50. Goodman MT, Hernandez B, Wilkens LR, Lee J, Le Marchand L, Liu LQ, et al. Eff ects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol Biomarkers Prev 1998; 7: 113-117.
51. Pron G, Belehradek J Jr, Orlowski S, Mir LM. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol 1994; 48: 301-310.
52. Mastruzzo C, Crimi N, Vancheri C. Role of oxidative stress in pulmonary fi brosis. Monaldi Arch Chest Dis 2002; 57: 173-176.
53. Mata M, Ruiz A, Cerda M, Martinez-Losa M, Cortijo J, Santangelo F, et al. Oral N-acetylcysteine reduces bleomycininduced lung damage and mucin Muc5ac expression in rats. Eur Respir J 2003; 22: 900-905.
54. Crooke ST, Bradner WT. Bleomycin, a review. J Med 1976; 7: 333-428.
55. White DA, Schwartzberg LS, Kris MG, Bosl GJ. Acute chest pain syndrome during bleomycin infusions. Cancer 1987; 59: 1582-1585.
56. Bowler RP, Nicks M, Warnick K, Crapo JD. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fi brosis. Am J Physiol Lung Cell Mol Physiol 2002; 282: L719-L726.
57. Boyaci H, Maral H, Turan G, Basyigit I, Dillioglugil MO, Yildiz F, et al. Eff ects of erdosteine on bleomycin-induced lung fi brosis in rats. Mol Cell Biochem 2006; 281: 129-137.
58. Sogut S, Ozyurt H, Armutcu F, Kart L, Iraz M, Akyol O, et al. Erdosteine prevents bleomycin-induced pulmonary fi brosis in rats. Eur J Pharmacol 2004; 494: 213-220.
59. Wang HD, Yamaya M, Okinaga S, Jia YX, Kamanaka M, Takahashi H, et al. Bilirubin ameliorates bleomycin-induced pulmonary fi brosis in rats. Am J Respir Crit Care Med 2002; 165: 406-411.
60. Sayed-Ahmed MM, Mansour HH, Gharib OA, Hafez HF. Acetyl-L-carnitine modulates bleomycin-induced oxidative stress and energy depletion in lung tissues. J Egypt Natl Canc Inst 2004; 16: 237-243.
61. Meister A. Glutathione metabolism. Methods Enzymol 1995; 251: 3-7.
62. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-492.
63. Agarwal R, Shukla GS. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 1999; 24: 1507-1514.
64. Issels RD, Nagele A, Eckert KG, Wilmanns W. Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharmacol 1988; 37: 881-888.
65. Sener G, Topaloglu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007; 20: 642-649.
66. Ali EN, Mansour SZ. Boswellic acids extract attenuates pulmonary fi brosis induced by bleomycin and oxidative stress from gamma irradiation in rats. Chin Med 2011; 6: 36.
67. Shouman SA, Abdel-Hamid MA, Hassan ZA, Mansour HH. Eff ects of ICRF-187 and L-carnitine on bleomycin-induced lung toxicity in rats. Saudi Pharm J 2002; 10: 184-189.
68. Kehrer JP. Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue. Toxicol 1989; 57: 69-82.
69. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515-540.
70. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999; 424: 83-95.
71. Yildirim Z, Kotuk M, Iraz M, Kuku I, Ulu R, Armutcu F, Ozen S. Attenuation of bleomycin-induced lung fi brosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther 2005; 18: 367-373.
72. Yildirim Z, Turkoz Y, Kotuk M, Armutcu F, Gurel A, Iraz M, et al. Eff ects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fi brosis in rats. Nitric Oxide 2004; 11: 156-165.
73. Iraz M, Erdogan H, Kotuk M, Yagmurca M, Kilic T, Ermis H, et al. Ginkgo biloba inhibits bleomycin-induced lung fi brosis in rats. Pharmacol Res 2006; 53: 310-316.
74. Kara H, Karatas F, Tug T, Canatan H, Karaoglu A. Protective eff ect of octreotide on intra-tracheal bleomycin-induced oxidative damage in rats. Exp Toxicol Pathol 2010; 62: 235-241.
75. Teixeira KC, Soares FS, Rocha LG, Silveira PC, Silva LA, Valenca SS, et al. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther 2008; 21: 309-316.
76. Erdogan H, Fadillioglu E, Kotuk M, Iraz M, Tasdemir S, Oztas Y, Yildirim Z. Eff ects of Ginkgo biloba on plasma oxidant injury induced by bleomycin in rats. Toxicol Ind Health 2006; 22: 47-52.
77. Giri SN, Chen ZL, Younker WR, Schiedt MJ. Eff ects of intratracheal administration of bleomycin on GSH-shuttle enzymes, catalase, lipid peroxidation, and collagen content in the lungs of hamsters. Toxicol Appl Pharmacol 1983; 71: 132-141.
78. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and eff ect of hyperbaric oxygen. Biochem J 1973; 134: 707-716.
79. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795.
80. Mattson DM, Ahmad IM, Dayal D, Parsons AD, Aykin-Burns N, Li L, et al. Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radic Biol Med 2009; 46: 232-237.
81. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1988; 1366: 177-196.